STERIS PE Ratio 2010-2022 | STE

Current and historical p/e ratio for STERIS (STE) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STERIS PE ratio as of September 23, 2022 is 20.78.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

STERIS PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-09-23 167.29 44.85
2022-06-30 205.66 $3.73 55.14
2022-03-31 240.71 $2.39 100.71
2021-12-31 241.88 $2.89 83.70
2021-09-30 202.62 $2.80 72.37
2021-06-30 204.22 $3.34 61.14
2021-03-31 188.17 $4.61 40.82
2020-12-31 186.81 $5.03 37.14
2020-09-30 173.28 $4.93 35.15
2020-06-30 150.52 $4.81 31.29
2020-03-31 136.97 $4.77 28.71
2019-12-31 148.82 $4.60 32.35
2019-09-30 140.73 $3.93 35.81
2019-06-30 144.64 $3.73 38.78
2019-03-31 124.08 $3.56 34.86
2018-12-31 103.27 $3.15 32.78
2018-09-30 110.24 $3.70 29.79
2018-06-30 100.89 $3.54 28.50
2018-03-31 89.43 $3.40 26.30
2017-12-31 83.51 $2.85 29.30
2017-09-30 84.10 $1.68 50.06
2017-06-30 77.26 $1.40 55.18
2017-03-31 65.61 $1.28 51.26
2016-12-31 63.40 $1.64 38.66
2016-09-30 68.49 $1.96 34.94
2016-06-30 64.16 $1.63 39.36
2016-03-31 66.07 $1.47 44.94
2015-12-31 69.79 $1.49 46.84
2015-09-30 60.18 $1.86 32.35
2015-06-30 59.69 $2.24 26.65
2015-03-31 65.09 $2.25 28.93
2014-12-31 60.07 $2.21 27.18
2014-09-30 49.98 $2.06 24.26
2014-06-30 49.54 $2.04 24.28
2014-03-31 44.23 $2.17 20.38
2013-12-31 44.51 $2.22 20.05
2013-09-30 39.61 $2.56 15.47
2013-06-30 39.34 $2.74 14.36
2013-03-31 38.01 $2.72 13.98
2012-12-31 31.57 $2.78 11.36
2012-09-30 32.06 $2.54 12.62
2012-06-30 28.20 $2.36 11.95
2012-03-31 28.26 $2.32 12.18
2011-12-31 26.51 $2.21 12.00
2011-09-30 25.86 $1.99 13.00
2011-06-30 30.73 $2.08 14.77
2011-03-31 30.21 $0.84 35.96
2010-12-31 31.75 $0.69 46.01
2010-09-30 28.80 $1.02 28.24
2010-06-30 26.81 $0.97 27.64
2010-03-31 28.93 $2.16 13.40
2009-12-31 23.96 $2.13 11.25
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $16.731B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
Alcon (ALC) Switzerland $29.415B 24.91
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19